Dr. Alan L. Ho, an esteemed graduate of Yale University School of Medicine, completed his residency in Internal Medicine at Massachusetts General Hospital before embarking on his distinguished career at MSKCC. Recognized for his innovative research in targeted therapies for thyroid and head and neck cancers, Dr. Ho has received multiple awards from the American Society of Clinical Oncology. His dedication to advancing cancer treatment is matched by his commitment to mentoring oncology fellows and junior researchers, fostering a collaborative and progressive environment within the medical community.
Dr. Alan L. Ho has over 20 years of experience in medical oncology at Memorial Sloan Kettering Cancer Center, specializing in advanced thyroid and head and neck cancer treatments. His clinical expertise includes the development and implementation of novel targeted therapies aimed at treating aggressive and refractory carcinomas. Dr. Ho is highly skilled in managing complex clinical trials, ensuring that patients receive cutting-edge treatments that align with the latest advancements in oncology.
Dr. Alan L. Ho, an esteemed graduate of Yale University School of Medicine, completed his residency in Internal Medicine at Massachusetts General Hospital before embarking on his distinguished career at MSKCC. Recognized for his innovative research in targeted therapies for thyroid and head and neck cancers, Dr. Ho has received multiple awards from the American Society of Clinical Oncology. His dedication to advancing cancer treatment is matched by his commitment to mentoring oncology fellows and junior researchers, fostering a collaborative and progressive environment within the medical community.